← Leaderboards
Mariette Barbier
West Virginia University
$8,169,304
Attributed
$8,169,304
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,169,304 · 3
By mechanism
R01$8,169,304 · 3
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Fredrick Heath Damron$7,032,693
- Nyles W. Charon$3,547,401
Others in their field
Other Emerging Leaders on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$250,731,514
Research focus
United States National Institutes Of HealthPathogenResponseBacteriaMissionInfectionVaccinationPublic HealthPseudomonas AeruginosaProductionAntibodiesLifeVaccine DevelopmentVaccine AntigenAdjuvantAntigensMethodologyVaccinesExtracellularImmunogenicityImmune ResponseDesignPeptidesB-Lymphocytes
Grant awards (13)
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections$2,779,955
R01 · FY2025 · AI · contact PI
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections$741,917
R01 · FY2024 · AI · contact PI
Peptide-vaccine development against Lyme disease$380,000
R01 · FY2024 · AI · contact PI
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition Proteins$491,796
R01 · FY2023 · AI · contact PI
Peptide-vaccine development against Lyme disease$380,000
R01 · FY2023 · AI · contact PI
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition Proteins$496,356
R01 · FY2022 · AI · contact PI
Peptide-vaccine development against Lyme disease$380,000
R01 · FY2022 · AI · contact PI
Peptide-vaccine development against Lyme disease Supplement$204,972
R01 · FY2022 · AI · contact PI
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition Proteins$506,996
R01 · FY2021 · AI · contact PI
Peptide-vaccine development against Lyme disease$380,000
R01 · FY2021 · AI · contact PI
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition Proteins$517,636
R01 · FY2020 · AI · contact PI
Peptide-vaccine development against Lyme disease$380,000
R01 · FY2020 · AI · contact PI
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition Proteins$529,676
R01 · FY2019 · AI · contact PI